Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OT-551 for Prevention of Nuclear Cataract Post-Vitrectomy
NCT00333060Phase 2Terminated
- Sponsor
- Othera Pharmaceuticals, Inc.
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OT-551 in nuclear cataract (NS), sponsored by Othera Pharmaceuticals, Inc.. Started Nov 2005; status: terminated.
02
Drugs
OT-551
03
Conditions
nuclear cataract (NS)
Beyond the preview
Go deeper on NCT00333060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00333060.